Shimura H, Shimura Y, Ohmori M, Ikuyama S, Kohn L D
Section on Cell Regulation, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, Maryland 20892, USA.
Mol Endocrinol. 1995 May;9(5):527-39. doi: 10.1210/mend.9.5.7565801.
An element, -186 to -176 base pairs (bp), in the minimal TSH receptor (TSHR) promoter binds thyroid transcription factor-1 (TTF-1) and is important for both constitutive expression and TSH/cAMP-induced negative autoregulation of the TSHR in thyroid cells. An element on the noncoding strand of the TSHR, contiguous with the 5'-end of the TTF-1 element, has single strand binding activity. It is distinct from the TTF-1 site, as evidenced by competition experiments using gel shift assays; but the association of the two elements is not random. Thus, the single strand binding protein (SSBP) element also exists contiguous to the 5'-end of an upstream TTF-1 site, -881 to -866 bp; mutation of two conserved nucleotides in each SSBP element results in the loss of SSBP binding and cross-competition. Transfection experiments indicate that full, constitutive TSHR gene expression in FRTL-5 thyroid cells requires the binding of both SSBPs and TTF-1, since mutation of either element halves thyroid-specific promoter activity, whereas mutation of both decreases promoter activity to values near those of a control vector. Transfection experiments with rat liver cells support their independent activities and show that the SSBP site contributes to TSHR gene expression in non-thyroid tissue. The SSBPs function conjointly with TTF-1 in thyroid-specific, TSH/cAMP-induced negative autoregulation of the TSHR. Thus, TSH or forskolin-treated FRTL-5 cells coordinately decrease TSHR RNA levels and TSHR DNA binding to both the SSBPs and TTF-1; also the maximal TSH/cAMP-induced decrease in gene expression requires both elements. The TSH-induced effect in each case is inhibited by cycloheximide; the TSH-induced decrease in SSBP/DNA complex formation requires the presence of insulin or calf serum, exactly as does TSH-induced down-regulation of TSHR RNA levels. In sum, full, constitutive expression of the TSHR in thyroid cells requires TTF-1 and the SSBPs to bind separate, contiguous elements on the TSHR promoter. TSH/cAMP decreases the binding of each factor to its respective site, thereby decreasing TSHR gene expression. The role of the SSBP and TTF-1 sites in constitutive TSHR expression and in TSH/cAMP-induced negative regulation of the TSHR is, therefore, additive and independent.
在最小促甲状腺激素受体(TSHR)启动子中,一个-186至-176碱基对(bp)的元件可结合甲状腺转录因子-1(TTF-1),对甲状腺细胞中TSHR的组成性表达以及TSH/cAMP诱导的负自调节均很重要。TSHR非编码链上与TTF-1元件5'端相邻的一个元件具有单链结合活性。通过凝胶迁移实验的竞争实验证明,它与TTF-1位点不同;但这两个元件的关联并非随机。因此,单链结合蛋白(SSBP)元件也存在于上游TTF-1位点-881至-86bp的5'端相邻处;每个SSBP元件中两个保守核苷酸的突变会导致SSBP结合和交叉竞争的丧失。转染实验表明,FRTL-5甲状腺细胞中TSHR基因的完全组成性表达需要SSBP和TTF-1的结合,因为任一元件的突变都会使甲状腺特异性启动子活性减半,而两个元件都突变则会使启动子活性降至接近对照载体的值。大鼠肝细胞的转染实验支持它们的独立活性,并表明SSBP位点有助于非甲状腺组织中TSHR基因的表达。SSBP与TTF-1在甲状腺特异性、TSH/cAMP诱导的TSHR负自调节中共同发挥作用。因此,TSH或福斯可林处理的FRTL-5细胞会协同降低TSHR RNA水平以及TSHR与SSBP和TTF-1的DNA结合;而且TSH/cAMP诱导的基因表达最大降低需要这两个元件。每种情况下TSH诱导的效应均被环己酰亚胺抑制;TSH诱导的SSBP/DNA复合物形成减少需要胰岛素或小牛血清的存在,这与TSH诱导的TSHR RNA水平下调完全相同。总之,甲状腺细胞中TSHR的完全组成性表达需要TTF-1和SSBP结合TSHR启动子上单独的相邻元件。TSH/cAMP会降低每个因子与其各自位点的结合,从而降低TSHR基因表达。因此,SSBP和TTF-1位点在TSHR组成性表达以及TSH/cAMP诱导的TSHR负调节中的作用是相加且独立的。